[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Doweyko, 2007 - Google Patents

Steroid nuclear hormone receptors: The allosteric conversation

Doweyko, 2007

Document ID
6596020323691824789
Author
Doweyko A
Publication year
Publication venue
Drug Development Research

External Links

Snippet

Nuclear hormone receptors (NHRs) regulate gene expression by forming complexes with small molecule ligands, other proteins, and DNA. Specific ligands, which include steroids, thyroids, and retinoids, are responsible for the regulation of complex processes in cellular …
Continue reading at analyticalsciencejournals.onlinelibrary.wiley.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells

Similar Documents

Publication Publication Date Title
Weikum et al. The nuclear receptor superfamily: A structural perspective
Suino et al. The nuclear xenobiotic receptor CAR: structural determinants of constitutive activation and heterodimerization
Bain et al. Nuclear receptor structure: implications for function
He et al. Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance
Li et al. Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor
Egea et al. Crystal structure of the human RXRα ligand-binding domain bound to its natural ligand: 9-cis retinoic acid
Zhang et al. ROR nuclear receptors: structures, related diseases, and drug discovery
Stehlin et al. X‐ray structure of the orphan nuclear receptor RORβ ligand‐binding domain in the active conformation
Nachtergaele et al. Structure and function of the Smoothened extracellular domain in vertebrate Hedgehog signaling
Kruse et al. Identification of COUP-TFII orphan nuclear receptor as a retinoic acid–activated receptor
Zhang et al. The mechanism of action of thyroid hormones
Pawlak et al. General molecular biology and architecture of nuclear receptors
McEwan Nuclear receptors: one big family
Cutress et al. Structural basis for the nuclear import of the human androgen receptor
Osz et al. Structural basis for a molecular allosteric control mechanism of cofactor binding to nuclear receptors
Wärnmark et al. Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation
EP0873361B1 (en) Crystals of the ligand-binding domain of the thyroid hormone receptor complexed to a ligand
Norris et al. A negative coregulator for the human ER
US6266622B1 (en) Nuclear receptor ligands and ligand binding domains
JP2003511467A (en) Crystal structure of the androgen receptor ligand binding domain
Teichert et al. Quantification of the Vitamin D Receptor− Coregulator Interaction
Xie et al. Structural basis of inhibition of ERα-coactivator interaction by high-affinity N-terminus isoaspartic acid tethered helical peptides
Kosinová et al. Insight into the structural and biological relevance of the T/R transition of the N-terminus of the B-chain in human insulin
Ossa et al. A review of the human sigma-1 receptor structure
Bianchetti et al. Alternative dimerization interfaces in the glucocorticoid receptor-α ligand binding domain